Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016
Global Data's pharmaceutical report offering, "Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global herpes simplex market. The report identifies the key trends shaping and driving the global herpes simplex market. The report also provides insight into the prevalent competitive landscape and the emerging players expected to bring significant shifts in the positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global herpes simplex therapeutics sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Data's team of industry experts.
Global Data finds that the global herpes simplex market was worth approximately $2.9 billion in 2009. The global herpes simplex therapeutics market is expected to grow at a CAGR of 11.1% between 2009 and 2016. The primary factor contributing to the increase in revenues over the forecast period is the increase in disease incidence. Presently the therapeutic regimen for Herpes Simplex is dominated by a range of DNA polymerase inhibitors which include Zovirax, Famvir, Valtrex, Denavir and OTC products such as Abreva and Aviralex. This market is a significantly generic zed market with many brands across the major seven geographies.
Scope
- Annualized global herpes simplex market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
- Key geographies covered in this report include the US (United States), the UK (united Kingdom), Italy, Spain, Germany, France and Japan.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include DNA polymerase inhibitors, Helicase-primase inhibitors, NFkB regulators, HSV-2 gene and nectin-1 receptor targetters, viral maturation inhibitors and PDI inhibitors.
- Analysis of the current and future market competition in the global herpes simplex market. Key market players covered are BioAlliance Pharma, Nutra Pharma Corporation and AiCuris GmbH & Co. KG.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the future market associated with herpes simplex therapeutics.
Reasons to buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global herpes simplex market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global herpes simplex market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global herpes simplex market landscape? – Identify, understand and capitalize.
Questions and Answers
The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths.
History of formula Early infant foods Throughout history, mothers who could not (or chose not to) breastfeed their babies either employed the use of a wet nurse or, less frequently
If you are one among the many thousands of teenagers or adults that suffer from acne infections on your torso, you have probably been looking for information on how to eliminate acne on your back. Large and aching cysts under the skin, general tenderness and redness and even pus filled pimples and sores are all signs of acne on your back. This condition is usually called bacne to differentiate it from face acne.
Nobody wants to be spotty. It is a universal truth. Regardless of how old we become--bad skin, be it the rare zit or full blown acne--is shameful. Acne, in particular, can be a problem for us for much longer than we had counted on when we first entered puberty as young adults. For a long time we've covered our faces with high-priced chemicals and products hoping to keep the acne far from us. But what if you could clear up your skin in much easier and less harmful ways?
No one really wants to be affected with zits. It really is just the simple truth. It doesn't matter how old we become, zits, pimples, acne -- terrible skin in whatever form it takes -- is embarrassing. Acne, in particular, can be a plague for us for considerably longer than we had counted on when we first entered puberty as young adults. We spend years slathering ourselves with every chemical and acne fighter we can find.
No one wishes to be seriously affected with spots. It is a universal truth. It doesn't matter how old we get, zits, pimples, acne -- bad skin in any form it takes -- is shameful. Acne particularly can plague us for far longer than we had planned when we were young adults entering puberty. For years we have covered our faces with high-priced chemicals and products aiming to keep the acne from us. What if you could assist your skin without having to be forced to take that type of drastic action?
Acne Vulgaris or commonly known as acne is a skin illness usually appears during our teenage years when one's hormones and skin oil glands are most productive. It may result in a great deal of changes not just in a person's physical appearance but psychologically at the same time.
The global dental implants market is expected to grow from $3.2 billion in 2010 to $4.2 billion in 2015 at a CAGR of 6% from 2010 to 2015. Europe currently forms the world's largest market for dental implants with a 42% market share
In pharma industry social media has emerged as an effective tool for marketing, consumer engagement, monitoring & analyzing user generated content and building & changing brand perception.
The changing market trends, with quick cycle of innovations have compelled market participants to clearly understand changing dynamics and focus on emerging technology and enhance market positions in terms of revenues, growth and geographical presence.
The global PCM market is expected to grow from $300.8 million in 2009 to $1,488.1 million in 2015, at an estimated CAGR of 31.7% from 2010 to 2015.
All the recent packaging technologies are devised keeping in mind the convenience of the consumers and the preservation and safety of food items. With rising average annual incomes, better home cooking facilities, and a shift of people towards supermarket or hypermarkets are the major factors driving this market.
Discuss this Article
